Global Shapley Explanations and LIME on HLA-B27 Positivity in Ankylosing Spondylitis Patients

Author:

Taş Nurmuhammet1,Seferoğlu Buminhan1,Naldan Muhammet Emin1,Naldan Hülya1,Kırboğa Kevser Kübra2,Işık Mesut2

Affiliation:

1. Erzurum Training and Research Hospital

2. Bilecik Seyh Edebali University

Abstract

Abstract Ankylosing spondylitis (AS), an autoimmune disease, has the HLA-B27 gene in more than 90% of its patients. This study investigated the ability of health parameters to predict the presence of the HLA-B-27 gene and clinical and demographic data used in diagnosing AS. For this purpose, various classification models were evaluated, and the best-performing RFC model was selected. In addition, the model's predictions are understood and explained using XAI techniques such as SHAP and LIME. The model development results show that the RFC model performs best (Accuracy:0.75, F1 Score:0.74, Recall:0.75, Precision:0.75, Brier Score:0.25, AUC: 0.76), and XAI techniques provide the ability to explain the decisions of this model. Among the health parameters, WBC, Hematocrit, uric acid, and gender were found to show the strongest association with HLA-B-27. This study aims to understand the genetic predisposition of AS and to illuminate the potential of XAI techniques in medical diagnosis. The study's strengths include comprehensive model evaluation, explainability of model decisions, and revealing the relationship between health parameters and HLA-B-27. In addition, this study considered ethical dimensions like the confidentiality of personal health data and the privacy of patients.

Publisher

Research Square Platform LLC

Reference77 articles.

1. Ankylosing spondylitis: etiology, pathogenesis, and treatments;Zhu W;Bone Res,2019

2. The impact of ankylosing spondylitis/axial spondyloarthritis on work productivity;Martindale J;Best Practice & Research Clinical Rheumatology,2015

3. Impact of ankylosing spondylitis on depression: a nationwide cohort study;Park J-S;Scientific reports,2019

4. Ankylosing spondylitis;Braun J;The Lancet,2007

5. McLeod, C., et al., Adalimumab, etanercept and infliximab for the treatment of ankylosing spondylitis: a systematic review and economic evaluation. Health technology assessment (Winchester, England), 2007. 11(28): p. 1-158, iii.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3